A detailed history of Charles Schwab Investment Management Inc transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 244,818 shares of ASRT stock, worth $303,574. This represents 0.0% of its overall portfolio holdings.

Number of Shares
244,818
Previous 244,818 -0.0%
Holding current value
$303,574
Previous $261,000 9.96%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$1.02 - $2.57 $210,041 - $529,222
-205,923 Reduced 45.69%
244,818 $261,000
Q3 2023

Nov 08, 2023

BUY
$2.52 - $5.69 $759,472 - $1.71 Million
301,378 Added 201.78%
450,741 $1.15 Million
Q2 2023

Aug 09, 2023

BUY
$5.0 - $7.66 $631,055 - $966,776
126,211 Added 545.14%
149,363 $809,000
Q1 2022

May 13, 2022

BUY
$2.06 - $3.0 $47,693 - $69,456
23,152 New
23,152 $67,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $59.7M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.